Bradley Mayhew is a licensed attorney and is registered to
practice before the U.S. Patent & Trademark Office. His
primary focus is the preparation and prosecution of patent
applications drawn to inventions in the areas of biotechnology,
pharmacology and chemistry.
Brad has significant work experience in the field of
Intellectual Property. Prior to founding
Mayhew Law, Brad worked as a Patent Agent at the law firm of
Sidley Austin Brown & Wood, where he conducted research in
support of patent litigation as well as patent infringement and
freedom-to-operate opinions. Brad also worked as an Intellectual
Property Manager at Medimmune where he assessed the potential
value and patentability of inventions, coordinated with
inventors and external counsel to direct patent prosecution, and
monitored competitive intellectual property developments. In
addition, Brad served for three years as a Patent Examiner at
the U.S. Patent & Trademark Office where he examined
applications drawn to inventions in the area of complex
biotechnology.
Brad has extensive knowledge of subjects relevant to the
biotechnology and pharmaceutical industries. He performed and
published research in the fields of enzymology and drug
metabolism as a researcher in the Department of Medicine at the
Indiana University School of Medicine. He also earned a graduate
degree from the school's Department of Pharmacology where his
studies included courses in pharmacology, physiology, medicinal
chemistry, bio-organic chemistry, biophysics, biochemistry and
physical biochemistry. Brad additionally holds an undergraduate
degree in biology with an emphasis in molecular genetics and a
minor in chemistry.
Prior to graduate study, Brad worked in Japan as an editor in
the Research Planning Department of Sankyo Co., Ltd., a major
Japanese pharmaceutical company. His work involved editing and
rewriting manuscripts from diverse fields including chemistry,
analytical chemistry, biochemistry, pharmacology, toxicology and
clinical medicine. The experience provided a unique insight into
the mechanisms for research and development conducted in the
pharmaceutical industry.
|
|
| ◦ |
Sidley Austin Brown & Wood LLP, Washington, DC
Patent Agent
|
| ◦ |
Medimmune, Inc., Gaithersburg, MD
Intellectual Property Manager
|
| ◦ |
U.S.
Patent & Trademark Office, Arlington, VA
Patent Examiner
|
| ◦ |
Indiana University School of Medicine, Indianapolis, IN
Research Analyst
|
| ◦ |
Sankyo Co., Ltd., Tokyo, Japan
Technical Editor
|
|
| ◦ |
American Bar Association, Intellectual Property Law
(ABA-IPL) |
| ◦ |
American Intellectual Property Law Association
(AIPLA) |
| ◦ |
Association of University Technology Managers
(AUTM) |
| ◦ |
Patent & Trademark Office Society
(PTOS) |
| ◦ |
National Association of Patent Practitioners
(NAPP) |
| ◦ |
International Society for the Study of Xenobiotics
(ISSX) |
| ◦ |
Phi Delta Phi
(ΦΔΦ) |
| ◦ |
Jones DR, Gorski JC, Hamman MA, Mayhew BS, Rider S, and Hall
SD
"Diltiazem Inhibition of CYP3A Activity is Due to Metabolite Intermediate
Complex Formation" Journal of Pharmacology and Experimental
Therapeutics, 1999, vol. 290, no. 3, pages 1116-1125 |
| ◦ |
Hall SD, Mayhew BS, Gorski JC, and Jones DR
"Principles of In Vitro Studies: Enzyme Kinetics,
Inhibition and Induction" in Drug-Drug Interactions:
Analyzing In Vitro-In Vivo Correlations, IBC USA, Inc., 1996 |
| ◦ |
Mayhew BS, Jones DR, Gorski JC, and Hall SD
"Non-Hyperbolic Interactions Between Substrates of
Cytochrome P450 (CYP) 3A4" Midwest Cytochrome P450
Symposium, 1996 |
| ◦ |
Mayhew BS, Gorski JC, and Hall SD
"Midazolam Hydroxylation Reveals the Potential for
Non-Hyperbolic Kinetics in Cytochrome P450 (CYP) 3A4"
ISSX Proceedings, 1995, vol. 8, page 3 |
|
